We found that xenograft tumors derived from PC9 cells that stably expressed KDM1A shRNA exhibited significantly slower growth rates and smaller tumor sizes, on average, compared to cells expressing the control shRNA (Figure 2J). Here, KDM1A is linked to neoplasm.